| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cpi-0610 | bromodomain-containing protein 4 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary Myelofibrosis[MeSHID:D055728] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Leukemia Myelocytic Acute[MeSHID:D015470] Myeloproliferative disease[MeSHID:D009196] |
NA | phase 3 | unknown |
| cpi-0610 | bromodomain-containing protein 4 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary Myelofibrosis[MeSHID:D055728] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Leukemia Myelocytic Acute[MeSHID:D015470] Myeloproliferative disease[MeSHID:D009196] |
NA | phase 3 | inhibitor |
| click here to return to the previous page | ||||||||